Oppenheimer is maintaining a Perform rating and a $47 price target on Aetna Inc. AET after the company announced its share repurchase program.
Says Oppenheimer, in its report, “Aetna announced that its Board of Directors authorized a share repurchase of up to $750M in common stock. This authorization is in addition to the approximately $315M approved previously. At today's closing price of $45.06/share, we believe this new authorization can lead to an annualized EPS accretion of $0.19, which translates to 4.3% of our FY2012 estimate of $4.38/share. Moreover, the Board also declared a quarterly cash dividend of $0.15/share, payable July 29, 2011.”
AET closed at $45.90 on Friday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in